108 related articles for article (PubMed ID: 10353444)
21. Targeting the CYP2B 1/cyclophosphamide suicide system to fibroblast growth factor receptors results in a potent antitumoral response in pancreatic cancer models.
Huch M; Abate-Daga D; Roig JM; González JR; Fabregat J; Sosnowski B; Mazo A; Fillat C
Hum Gene Ther; 2006 Dec; 17(12):1187-200. PubMed ID: 17069538
[TBL] [Abstract][Full Text] [Related]
22. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer.
Günzburg WH; Salmons B
Acta Biochim Pol; 2005; 52(3):601-7. PubMed ID: 16175235
[TBL] [Abstract][Full Text] [Related]
23. Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.
Kammertoens T; Gelbmann W; Karle P; Alton K; Saller R; Salmons B; Günzburg WH; Uckert W
Cancer Gene Ther; 2000 Apr; 7(4):629-36. PubMed ID: 10811482
[TBL] [Abstract][Full Text] [Related]
24. Small agarose microcapsules with cell-enclosing hollow core for cell therapy: transplantation of Ifosfamide-activating cells to the mice with preestablished subcutaneous tumor.
Sakai S; Hashimoto I; Tanaka S; Salmons B; Kawakami K
Cell Transplant; 2009; 18(8):933-9. PubMed ID: 19500478
[TBL] [Abstract][Full Text] [Related]
25. An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy.
Chase M; Chung RY; Chiocca EA
Nat Biotechnol; 1998 May; 16(5):444-8. PubMed ID: 9592392
[TBL] [Abstract][Full Text] [Related]
26. Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors.
Sakai S; Kawabata K; Tanaka S; Harimoto N; Hashimoto I; Mu C; Salmons B; Ijima H; Kawakami K
Mol Cancer Ther; 2005 Nov; 4(11):1786-90. PubMed ID: 16276000
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of cyclophosphamide sensitivity in squamous cell carcinoma transfected with cytochrome P-450 2B1.
Iida M; Kojima H; Miyazaki H; Manome Y
Am J Otolaryngol; 2005; 26(1):22-7. PubMed ID: 15635577
[TBL] [Abstract][Full Text] [Related]
28. Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics.
Chen CS; Lin JT; Goss KA; He YA; Halpert JR; Waxman DJ
Mol Pharmacol; 2004 May; 65(5):1278-85. PubMed ID: 15102956
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide.
Manome Y; Wen PY; Chen L; Tanaka T; Dong Y; Yamazoe M; Hirshowitz A; Kufe DW; Fine HA
Gene Ther; 1996 Jun; 3(6):513-20. PubMed ID: 8789801
[TBL] [Abstract][Full Text] [Related]
30. FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein.
Lengler J; Holzmüller H; Salmons B; Günzburg WH; Renner M
Anal Biochem; 2005 Aug; 343(1):116-24. PubMed ID: 15955524
[TBL] [Abstract][Full Text] [Related]
31. Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1.
Fields WR; Morrow CS; Doehmer J; Townsend AJ
Carcinogenesis; 1999 Jun; 20(6):1121-5. PubMed ID: 10357798
[TBL] [Abstract][Full Text] [Related]
32. New proteins in the rat CYP2B subfamily: presence in liver microsomes of the constitutive CYP2B3 protein and the phenobarbital-inducible protein product of alternatively spliced CYP2B2 mRNA.
Desrochers M; Christou M; Jefcoate C; Belzil A; Anderson A
Biochem Pharmacol; 1996 Oct; 52(8):1311-9. PubMed ID: 8937440
[TBL] [Abstract][Full Text] [Related]
33. Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic mice.
Skarin T; Becher R; Bucht A; Duvefelt K; Bohm S; Ranneberg-Nilsen T; Lilleaas EM; Schwarze PE; Toftgârd R
Am J Respir Cell Mol Biol; 1999 Aug; 21(2):177-84. PubMed ID: 10423399
[TBL] [Abstract][Full Text] [Related]
34. A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.
Winiarczyk S; Gradski Z; Kosztolich B; Gabler C; König G; Renner M; Saller RM; Prosl H; Salmons B; Günzburg WH; Hain J
J Mol Med (Berl); 2002 Sep; 80(9):610-4. PubMed ID: 12226743
[No Abstract] [Full Text] [Related]
35. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
Chen CS; Jounaidi Y; Waxman DJ
Drug Metab Dispos; 2005 Sep; 33(9):1261-7. PubMed ID: 15919850
[TBL] [Abstract][Full Text] [Related]
36. Repression of phenobarbital-dependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures.
Hirsch-Ernst KI; Schlaefer K; Bauer D; Heder AF; Kahl GF
Mol Pharmacol; 2001 Jun; 59(6):1402-9. PubMed ID: 11353799
[TBL] [Abstract][Full Text] [Related]
37. E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells.
Elliott MJ; Farmer MR; Atienza C; Stilwell A; Dong YB; Yang HL; Wong SL; McMasters KM
Tumour Biol; 2002; 23(2):76-86. PubMed ID: 12065845
[TBL] [Abstract][Full Text] [Related]
38. Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study.
Cerny T; Martinelli G; Goldhirsch A; Terrier F; Joss R; Fey MF; Brunner KW; Küpfer A
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S135-8. PubMed ID: 1795002
[TBL] [Abstract][Full Text] [Related]
39. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
[TBL] [Abstract][Full Text] [Related]
40. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
Huan JY; Streicher JM; Bleyle LA; Koop DR
Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
